Kikuchi-Fujimoto disease: State of the art
More details
Hide details
Department of Otolaryngology, Medical University of Gdansk, Poland
Submission date: 2020-06-03
Final revision date: 2020-08-27
Acceptance date: 2020-08-27
Online publication date: 2021-06-07
Corresponding author
Dmitry Tretiakow   

Department of Otolaryngology, Medical University of Gdansk, Smoluchowskiego 17, 80-214 Gdańsk, Poland. Tel. +48 583 493 110; fax: +48 583 493 12.
Pol. Ann. Med. 2022;29(1):78-82
Kikuchi-Fujimoto disease (KFD), also called histiocytic necrotizing lymphadenitis, is a rare disease that occurs with swollen lymph nodes and associated fever. This disease occurs in both children and adults.

The aim of our work was to review the literature and to remind family doctors, otolaryngologists, hematologists and rheumatologists about this rare disease that should be included in the differential diagnosis of long-term cervical lymphadenopathy.

Material and methods:
Current information on Kikuchi-Fujimoto disease was sought and presented based on literature that was published in reputable magazines in the period 2007–2020 in English. We searched for articles in the Medline, PubMed, and Scopus databases.

Results and discussion:
KFD occurs in both children and adults. This disease is found all over the world, most often in the Asian population. The etiology of Kikuchi-Fujimoto disease is not entirely known, however, two causal theories are suspected, which are discussed in detail in our article. The course of the disease is mild and usually disappears on its own. A biopsy of an involved lymph node presented as the standard for diagnosis. KFD treatment was causal – nonsteroidal anti-inflammatory drugs and/or glucocorticosteroids were used.

There are few reports in the literature about Kikuchi-Fujimoto disease. KFD is associated with cervical lymphadenopathy and associated fever. If the diagnosis of the above-mentioned symptoms is not obvious, then in the differential diagnosis rarer diseases, such as KFD, should be included.

This work not supported in any foundation.
The authors declare no potential conflicts of interest concerning the authorship and publication of this article.
Nair I, Balan S, Phalak P, Daniel M. Clinicopathologic spectrum of necrotizing lymphadenitis. Indian J Pathol Microbiol. 2020;2020;63(1):60–63.
Singh JM, Shermetaro CB. Kikuchi-Fujimoto disease in Michigan: A rare case report and review of the literature. Clin Med Insights Ear Nose Throat. 2019;12:1179550619828680.
Salamat S, Chan J, Jolly K, et al. Kikuchi–Fujimoto Disease and prognostic implications. Head Neck Pathol. 2020;14(1):272–275.
Selvanathan SN, Suhumaran S, Sahu VK, Chong CY, Tan NWH, Thoon KC. Kikuchi-Fujimoto disease in children. J Paediatr Child Health. 2020;56(3):389–393.
Xu S, Sun W, Liu J. Kikuchi-Fujimoto disease: A case report and the evaluation of diagnostic procedures. BMC Oral Health. 2019;19(1):223.
Sharma K, Otieno F, Shah R. Case report of Kikuchi-Fujimoto disease from Sub-Saharan Africa: An important mimic of tuberculous lymphadenitis. Case Rep Med. 2020;2020:4385286.
Jiménez-Heffernan JA, Muñoz-Hernández P, Bárcena C. Kikuchi-Fujimoto disease-like inflammatory reaction in a silicone breast implant seroma. Acta Cytol. 2020;64(4):386–389.
Cao NT, Nguyen HT, Pham VHT, et al. Reactive hemophagocytic lymphohistiocytosis-associated Kikuchi-Fujimoto disease after a Staphylococcus epidermidis cutaneous infection. JCR J Clin Rheumatol. 2019;27(3):e96–e97.
Arslan A, Kraus CL, Izbudak I. Optic neuritis as an isolated presentation of Kikuchi–Fujimoto disease in a pediatric patient. Balkan Med J. 2020;12;37(3):172–173.
Moyer A, Hanafi ZM, Scordino T, Bronze M. Kikuchi-Fujimoto disease: An atypical presentation of a rare disease. Cureus. 2019;11(2):e3999.
Ahn SS, Lee B, Kim D, et al. Evaluation of macrophage activation syndrome in hospitalised patients with Kikuchi-Fujimoto disease based on the 2016 EULAR/ACR/PRINTO classification criteria. PLoS One. 2019;18;14(7):e0219970.
Shabana M, Warnack W. An atypical neurologic complication of Kikuchi-Fujimoto disease. Neurol Neuroimmunol Neuroinflamm. 2020;16;7(3):e707.
Marunaka H, Orita Y, Tachibana T, et al. Kikuchi-Fujimoto disease: Evaluation of prognostic factors and analysis of pathologic findings. Acta Oto-Laryngologica. 2016;136(9):944–947.
Sukswai N, Jung HR, Amr SS, et al. Immunopathology of Kikuchi-Fujimoto Disease: A reappraisal using novel immunohistochemistry combinations. Histopathology. 2019;77(2):262–274.
Journals System - logo
Scroll to top